Concepedia

Alan Hruza

AH

29

Publications

2.7K

Citations

21

H-Index

1993

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

LabCorp (United States)

United States Military Academy

Alan Hruza is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

1993–2018

29

Publications

29

Discovery of a Novel ERK Inhibitor with Activity in Models of Acquired Resistance to BRAF and MEK Inhibitors

Erick J. Morris, Sharda Jha, Clifford R. Restaino et al. · Cancer Discovery · 2013 · 673 citations · Full text

, , +20

Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation.

Thierry Fischmann, Alan Hruza, Xiao Da Niu et al. · Nature Structural Biology · 1999 · 452 citations

, , +9

Structure of the insulin receptor–insulin complex by single-particle cryo-EM analysis

Giovanna Scapin, Venkata P. Dandey, Zhening Zhang et al. · Nature · 2018 · 261 citations · Full text

, , +5

Zinc mediated dimer of human interferon-α2b revealed by X-ray crystallography

R. Radhakrishnan, Leigh J. Walter, Alan Hruza et al. · Structure · 1996 · 224 citations · Full text

, , +5

Discovery of Dinaciclib (SCH 727965): A Potent and Selective Inhibitor of Cyclin-Dependent Kinases

Kamil Paruch, Michael P. Dwyer, Carmen Álvarez et al. · ACS Medicinal Chemistry Letters · 2010 · 174 citations · Full text

, , +21

Rows per page

1–5 of 29